Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination

A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimm...

Descripción completa

Detalles Bibliográficos
Autores principales: Brubaker, Jon Elliott D, Casaccio, Christopher L, Brazeau, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236645/
https://www.ncbi.nlm.nih.gov/pubmed/35774705
http://dx.doi.org/10.7759/cureus.25339
Descripción
Sumario:A 35-year-old Asian female with a pertinent past medical history of autoimmune hepatitis presented with an acute recurrence of autoimmune hepatitis two weeks after receiving the second dose of the Pfizer-BioNTech messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Nine cases of autoimmune hepatitis after the administration of the COVID-19 vaccine have been reported, but this is the first documented case of a reactivation of autoimmune hepatitis in remission. As recommendations for COVID-19 vaccinations and booster shots continue to evolve, all adverse events should be reported to better educate and monitor patients.

Ejemplares similares